Sexually Transmitted Infections

Visby Medical has announced its second generation point of care test for detecting sexually transmitted diseases in women has received 510(k) clearance and a CLIA waiver from the FDA.

The new guidance is the first update since 2008, replacing the previous risk-based recommendations.

The therapy, bepirovirsen, is an antisense oligonucleotide that targets all Hepatitis B (HBV) messenger RNAs, and the company is hoping it will become a functional cure.

Individuals that did not respond had a lower percentage of naïve T cells compared to responders, while responders had a lower percentage of Th2 and CD4 central memory subsets before vaccination.

A recent study highlights barriers to pregnancy prevention for women without permanent housing.

Kenneth J. Tomecki, MD, discussed the clinical relevance of sexually transmitted diseases (STDs) to dermatology and outlined what to look for and how to treat various conditions at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

The handheld STI testing device makes its way into pediatric urgent care clinics across Alabama, Tennessee, and Louisiana.

Consensus group discussion resulted in a shift from results-based to risk-based management for cervical cancer screening.

A study found trans people were not substantively included in many countries’ HIV national strategic plans, despite being disproportionately impacted by HIV/AIDS.

People are being diagnosed with chlamydia and gonorrhea at a higher rate than ever before, according to the Centers for Disease Control and Prevention (CDC).

New guidelines from the Centers for Disease Control and Prevention (CDC) for the screening of sexually transmitted infections (STIs) offer new ways to ask common questions.

A cross-sectional study in the journal Sexually Transmitted Infections has found that Mycoplasma genitalium (MG) is just as prevalent as Chlamydia trachomatis (CT) among women seen at a sexual health center in Australia.

The CDC updated its guidelines for diagnosing and treating STIs, which included updates on the diagnosis and treatment of bacterial vaginosis (BV) in pregnant and nonpregnant women.

For cervical cancer screening, human papillomavirus (HPV)–based screening modalities detect significantly more abnormal cervical cells than traditional liquid-based cytology (LBC) approaches, according to a study in JAMA Network Open.

Significant updates occurred in women’s health issues while the world was in survival mode.

A narrative review identified gaps in knowledge and considerations for informing sexually transmitted infection (STI) screening guidelines and treatment to improve the health of pregnant women and children.

This article is on based on information presented at the Society for Maternal-Fetal Medicine’s 2021 Virtual Annual Meeting, which was held Jan. 25 to Jan. 30.

The January issue of Contemporary OB/GYN® featured a peer-reviewed article on syphilis in pregnancy.

Diagnosis and treatment of “the great imitator” that has resurged.

With the beginning of 2021, we are eager for a resolution to the pandemic.

The Healthy People 2020 goal of HPV vaccine coverage was set at 80% by 15 years of age.

Women with high-grade cervical dysplasia are much less likely to have recurrence after primary conization if they undergo laser conization than a loop electrosurgical excision procedure (LEEP), according to a 5-year follow-up study.

For the literature review, the authors searched PubMed, ScienceDirect and Embase for English language articles on drug resistance, with 58 articles for inclusion.

The Centers for Disease Control and Prevention (CDC) recommends using nucleic-acid amplification tests (NAAT) when testing female patients under the age of 25 for Chlamydia trachomatis.

Existing research suggests that reminder messages, or state immunization information systems autodialer centralized reminder and recall (C-R/R) messages, are likely to result in higher child vaccination rates.

Results from a longitudinal study suggest that bacteria in the cervicovaginal microbiome (CVM) may play a role in risk of progression of high-risk human papillomavirus (HR-HPV) to cervical precancer.

Sexual transmission of COVID-19 is unlikely, according to a new international study published in Fertility & Sterility.

New research suggests that certain sexually transmitted infections (STIs), such as Trichomonas vaginalis and Neisseria gonorrhea, may contribute to a higher risk of adverse pregnancy outcomes and preterm birth (PTB) in adolescents.

A new study suggests that certain sexually trasmitted infections, such as herpes simplex virus 2, may have a role in the development of certain types of ovarian cancer.